financetom
Business
financetom
/
Business
/
Carlyle Group enters Indian auto parts industry with Highway-Roop platform buy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carlyle Group enters Indian auto parts industry with Highway-Roop platform buy
Feb 12, 2025 10:20 PM

Feb 13 (Reuters) - U.S.-based investment firm Carlyle

Group ( CG ) has entered India's auto components market by

buying a controlling stake in an entity formed by the

combination of Indian auto parts companies Highway Industries

and Roop Automotives.

Equity for the investment will come from funds affiliated

with Carlyle Asia Partners, the firm said on Wednesday without

disclosing any financial details.

Highway Industries is a manufacturer of powertrain parts and

subsystems. Roop Automotives produces steering yokes and exports

them to Europe and North America.

The founders of both the Indian firms will continue to hold

stakes in the merged platform, Carlyle said.

The size of the deal is about $400 million, where Carlyle

will own 65%-70% stake in the platform, the Economic Times

reported citing sources.

On January 7, India's competition regulator gave its nod to

a transaction that constituted a securities swap between Highway

and Roop, and a 68.9% stake buy in Roop by Carlyle.

(Reporting by Adwitiya Srivastava in Bengaluru; Editing by

Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tiziana Life Sciences Names Ivor Elrifi as CEO
Tiziana Life Sciences Names Ivor Elrifi as CEO
Aug 19, 2024
08:05 AM EDT, 08/19/2024 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Monday it has named Ivor Elrifi as chief executive officer, effective immediately. He succeeds Gabriele Cerrone, who served as chief executive and will remain as executive chairman of the board. Elrifi previously served as global head of the patent group at Cooley and global head of...
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
Aug 19, 2024
08:04 AM EDT, 08/19/2024 (MT Newswires) -- PharmaTher Holdings Ltd. ( PHRRF ) , a specialty pharmaceutical company, announced Monday Sairiyo Therapeutics Inc., a company that is 49% owned by PharmaTher ( PHRRF ) and 51% owned by PharmaDrug Inc. ( LMLLF ) , has received approval by the Australian Human Research Ethics Committee to initiate a first-in-human Phase 1...
Laramide Resources Says Australian Drilling Proceeding as Planned
Laramide Resources Says Australian Drilling Proceeding as Planned
Aug 19, 2024
08:05 AM EDT, 08/19/2024 (MT Newswires) -- Laramide Resources ( LMRXF ) , a uranium mine development and exploration company with assets in the United States and Australia, on Monday provided an update on its drilling activities at the Westmoreland Uranium Project in Queensland, Australia. This season's exploration drilling campaign is comprised of up to 12,000 metres of diamond and...
Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises
Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises
Aug 19, 2024
08:01 AM EDT, 08/19/2024 (MT Newswires) -- Tonix Pharmaceuticals Holding ( TNXP ) reported a Q2 loss Monday of $19.28 per diluted share, narrowing from a loss of $49.23 a year earlier. Three analysts polled by Capital IQ expected a loss of $3.27. Revenue for the quarter ended June 30 was $2.21 million, compared with no revenue a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved